|
Sami-Sabinsa Group, a pioneer and global leader in health science was awarded with the Best Patent Portfolio award in SME (Life Science and Pharma) and Best Trademark Portfolio in SME (Life Science and Pharma) at Confederation of Indian Industry (CII) Industrial Intellectual Property Awards held recenty.
CII Industrial Intellectual Property (IP) Award is the recognition and celebration of Indian enterprises which have embraced IP generation and protection to fuel their economic growth and lend a hand towards the country’s economic progress.
The purpose of these awards is to encourage organizations to foster a culture of IP and its commercialization, bring the achievements of enterprises in public domain, set up linkages with academic and research institutions in India and abroad, inform the government about IP-driven enterprises and engage such enterprises in policy making exercises.
“These awards are recognition of the pioneering work accomplished in the IP domain by the Sami-Sabinsa team,” said Dr Muhammed Majeed, founder and chairman, Sami-Sabinsa Group.
“With research at the core of everything we do, Sami-Sabinsa continues to develop innovative, patented nutraceutical and cosmeceutical products for our clients globally,” Dr Majeed added.
Founded in 1988 by Dr. Muhammed Majeed, Sami-SabinsaGroup has a sizeable patent portfolio comprising over 277 granted patents and 300 pending patent applications worldwide. Headquartered in Bengaluru, the group has independent research divisions including natural drugs, phytochemistry, synthetic chemistry, tissue culture, biotechnology, analytical R&D, biological research, microbiology, and formulations R&D all of which coordinate in a synergistic work model to create products meeting international standards.
Sami-Sabinsa Group, a pioneer and global leader in health science, is a leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals and probiotics.
A team of over 120 research scientists work tirelessly to discover and develop standardized natural extracts that render alternative therapy to emerging nutritional and health requirements across the globe.
Demonstrating its commitment to sustainable development, Sami-Sabinsa, under the visionary leadership of Dr. Majeed, pioneered the contract farming model deploying close to 40,000 acres of land in India.
Sami-Sabinsa Group manufactures its products per global standards at its seven state-of-the-art manufacturing facilities located in Bengaluru, Hyderabad and Utah (USA) which are all accredited with FSSC 22000, FSSAI and USP GMP.
The Sami-Sabinsa group is a global organization with presence in the USA (New Jersey & Utah), Australia, Canada, China, Germany, India, Indonesia, Japan, Malaysia, Philippines, Poland, South Africa, South Korea, Thailand, the United Arab Emirates (UAE) and Vietnam.
|